Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $22.8 billion by market cap, the company develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The insulin infusion systems maker is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Thursday, Nov. 6. Ahead of the event, analysts expect PODD to report a profit of$1.13 per share on a diluted ...